About a third of small CPA firms have implemented a measure that prevents fraudsters from sending fake emails in their name but the majority remain vulnerable to impersonation.
AstraZeneca will tap AI-focused insitro to find new targets for metabolic dysfunction-associated steatohepatitis and cardiomyopathies, following the Phase 3 failure of its Ionis-partnered Wainua in transthyretin-mediated amyloid cardiomyopathy.
A new biotech co-founded by Paul Stoffels has formed to take on the CAR T cell assets of Galapagos almost a year after the company—now known as Lakefront Biotherapeutics—abandoned them.
The IRS and its Criminal Investigation division partnered with U.S. Attorneys’ Offices around the country and uncovered more than $490 million in tax fraud.